Publication | Closed Access
Avelumab (MSB0010718C; anti-PD-L1) in patients with metastatic urothelial carcinoma progressed after platinum-based therapy or platinum ineligible
19
Citations
0
References
2016
Year
Platinum-based TherapyUrologyMetastatic Urothelial CarcinomaGenitourinary CancerMedicineImmune Checkpoint InhibitorCancer TreatmentOncologyRadiation OncologyMolecular Oncology
No additional data available for this publication yet. Check back later!